Adelaide Research & Scholarship
Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/103272
| Citations | ||
| Scopus | Web of Science® | Altmetric |
|---|---|---|
|
?
|
?
|
|
| Type: | Journal article |
| Title: | Analysis of KRAS/NRAS mutations in a phase III study of panitumumab with FOLFIRI compared with FOLFIRI zlone as second-line treatment for metastatic colorectal cancer |
| Author: | Peeters, M. Oliner, K. Price, T. Cervantes, A. Sobrero, A. Ducreux, M. Hotko, Y. André, T. Chan, E. Lordick, F. Punt, C. Strickland, A. Wilson, G. Ciuleanu, T. Roman, L. Van Cutsem, E. He, P. Yu, H. Koukakis, R. Terwey, J. et al. |
| Citation: | Clinical Cancer Research, 2015; 21(24):5469-5479 |
| Publisher: | American Association for Cancer Research |
| Issue Date: | 2015 |
| ISSN: | 1078-0432 1557-3265 |
| Statement of Responsibility: | Marc Peeters ... Timothy J. Price ... et al. |
| Abstract: | Abstract not available |
| Keywords: | Humans Colorectal Neoplasms Neoplasm Metastasis Camptothecin Fluorouracil Leucovorin Proto-Oncogene Proteins B-raf Antineoplastic Combined Chemotherapy Protocols Antibodies, Monoclonal Treatment Outcome Retreatment Proportional Hazards Models Survival Analysis DNA Mutational Analysis Mutation Genes, ras Exons Adult Aged Aged, 80 and over Middle Aged Female Male Panitumumab |
| Rights: | ©2015 American Association for Cancer Research. |
| DOI: | 10.1158/1078-0432.CCR-15-0526 |
| Published version: | http://dx.doi.org/10.1158/1078-0432.ccr-15-0526 |
| Appears in Collections: | Aurora harvest 3 Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.